Details for New Drug Application (NDA): 204331
✉ Email this page to a colleague
The generic ingredient in EZETIMIBE is ezetimibe; simvastatin. There are twenty-four drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ezetimibe; simvastatin profile page.
Summary for 204331
Tradename: | EZETIMIBE |
Applicant: | Zydus Pharms |
Ingredient: | ezetimibe |
Patents: | 0 |
Pharmacology for NDA: 204331
Physiological Effect | Decreased Cholesterol Absorption |
Medical Subject Heading (MeSH) Categories for 204331
Suppliers and Packaging for NDA: 204331
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EZETIMIBE | ezetimibe | TABLET;ORAL | 204331 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-773 | 68382-773-01 | 100 TABLET in 1 BOTTLE (68382-773-01) |
EZETIMIBE | ezetimibe | TABLET;ORAL | 204331 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-773 | 68382-773-05 | 500 TABLET in 1 BOTTLE (68382-773-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Jun 12, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription